Frederic (fred) Baribaud PhD

Frederic Baribaud holds a PhD from the University of Lausanne and has conducted his post-doctoral studies at the University of Pennsylvania. He has worked at Incyte Corporation in a discovery role on target validation and as a Compound Team Co-Lead for small molecular inhibitors. For the past ten years, he has been working at Janssen R&D in Immunology Biomarkers on various inflammatory diseases. In his current role as Scientific Director he is focusing on obtaining disease rational for targets and patient segmentation for inflammatory bowel diseases.